首页> 外文OA文献 >HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR

【2h】

HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR

机译：丙型肝炎治疗肾移植和慢性肾病患者：含Sofosbuvir直接作用抗病毒方案的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fernanda Bellini Lunardi MICHELS; Ana Cristina de Castro AMARAL; Roberto José de CARVALHO-FILHO; Gustavo de Almeida VIEIRA; Ana Lucia da Silva SOUZA; Maria Lucia Gomes FERRAZ;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of sofosbuvir based antiviral therapy for chronic hepatitis C infection in patients with advanced chronic kidney disease [J] . Shahid Rasool, Ahmad N. Babar, Muhammad Wasif Baig, International Journal of Research in Medical Sciences . 2019,第10期

机译：基于索非布韦的抗病毒治疗对晚期慢性肾脏病患者的慢性丙型肝炎感染的疗效和安全性
2. Safety and Efficacy of Current Direct-Acting Antiviral Regimens in Kidney and Liver Transplant Recipients With Hepatitis C: Results From the HCV-TARGET Study [J] . Saxena Varun, Khungar Vandana, Verna Elizabeth C., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第4期

机译：肾脏和肝脏移植受者在肝炎C的安全性和有效性，丙型肝炎：HCV-靶研究结果
3. May direct-acting antiviral regimens for chronic hepatitis C virus infections have neuropsychiatric adverse drug reactions? A pilot study conducted in patients receiving sofosbuvir-based regimens in the real-life setting [J] . Davide Simeone, Anna Maria Spera, G. Tosone, Drugs & therapy perspectives: for rational drug selection and use . 2017,第9期

机译：可直接作用抗病毒方案用于慢性丙型肝炎病毒感染具有神经精神性不良药物反应吗？在现实生活环境中接受基于Sofosbuvir的方案的患者进行的试验研究
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Clinical and economic outcomes of direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid. [D] . Pham, Timothy Tung. 2016

机译：直接作用抗病毒药在俄克拉荷马州医疗补助中的慢性丙型肝炎感染的临床和经济结果。
6. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease [O] . Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma 2020

机译：直接作用抗病毒药对慢性肾脏病患者的慢性丙型肝炎的安全性和有效性
7. Efficacy and safety of sofosbuvir based antiviral therapy for chronic hepatitis C infection in patients with advanced chronic kidney disease [O] . Shahid Rasool, Ahmad N. Babar, Muhammad Wasif Baig, 2019

机译：基于Sofosbuvir基于慢性肾病患者慢性丙型肝炎抗病毒治疗的疗效和安全性

HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR

著录项

引文网络

相似文献

相关主题

期刊订阅